Financials
Income statement
Fiscal date | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 |
---|---|---|---|---|
Total reported revenue | 42.9B | 40.7B | 41.3B | 45.3B |
Cost of revenue | 24.8B | 24.3B | 24.2B | 25.5B |
Gross profit | 18.1B | 16.4B | 17.1B | 19.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 14.7B | 15.2B | 14.2B | 14.7B |
Other operating expenses | — | — | — | — |
Operating income | 3.4B | 1.2B | 2.9B | 5.1B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | -84.3M | -91.6M | 139.2M | 29.3M |
Pretax income | 3.4B | 1.2B | 3.1B | 5.2B |
Tax provision | 714.4M | 392.0M | 183.2M | 926.9M |
Net income | 2.7B | 773.0M | 2.9B | 4.3B |
Basic EPS | 0.5 | 0.1 | 0.5 | 0.8 |
Diluted EPS | 0.5 | 0.1 | 0.5 | 0.8 |
Basic average shares | 5.4B | 5.4B | 5.4B | 5.4B |
Diluted average shares | 5.4B | 5.4B | 5.4B | 5.5B |
EBITDA | 4.1B | 1.9B | 3.8B | 5.7B |
Net income from continuing op. | 2.7B | 773.0M | 2.9B | 4.3B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |